AHCA, Obamacare Repeal, and the In Vitro Diagnostics (IVD) Industry

AHCA, Obamacare Repeal, and the In Vitro Diagnostics (IVD) Industry

Diagnostics companies seek to resolve four main policy issues, according to industry interviews and public statements


5 Trends to Watch in the Liquid Biopsy Market

5 Trends to Watch in the Liquid Biopsy Market

The liquid biopsy market is experiencing four trends driving growth, and one trend that should be watched as a limited trend.


VIDEO: What We'll Be Watching Out for at the #AACC2017 Clinical Expo

VIDEO: What We'll Be Watching Out for at the #AACC2017 Clinical Expo

Test migration, new assays, molecular POC and other trends will be what we are tracking at this year's #AACC2017


What is the Size of the Indonesian IVD Market?

What is the Size of the Indonesian IVD Market?

With a combination of hospitals and community health centers, public and private laboratories, the sprawling Southeast asian nation's rising middle class presages a growing IVD market. This article discusses the Indonesian IVD market, including growth factors and multiple segments.


Brazil Demands More, Fueling IVD Market

Brazil Demands More, Fueling IVD Market

Private healthcare spending can be the difference between a strong market or an under-performing one. In many emerging markets, the first thing to develop once consumers obtain more economic strength is disease detection. That bodes well for the Brazil IVD market.


Top 5 Life Sciences Market Stories of June 2017

Top 5 Life Sciences Market Stories of June 2017

From 'Living Diagnostics' to FDA action on a painkiller drug, we look at the top stories in the life sciences market this month. Stories featured included.

-Drug maker sponsors reality TV show
-FDA asks maker to pull Opana ER due to abuse risk
-“Living Diagnostics” a possibility
-Lead test recalled due to inaccurate results
-Bristol-Myers Squibb and QIAGEN partner on NGS technology

  • by Bruce Carlson
  • June 5 2017


6 Predictions for The 2017 EMR Market

6 Predictions for The 2017 EMR Market

The EMR Market is facing an "Era of Disruption," according to Kalorama Information's new report. Physicians have adopted EHR but are not pleased with their electronic medical records systems according to surveys. A new administration is expected to set new policies. Kalorama looks at what's reasonable and what's likely in EHR policy and the EMR industry.

  • by Emil Salazar
  • May 30 2017


Robotic Surgery Develops as a Platform for Augmented Reality and Virtual Reality

Robotic Surgery Develops as a Platform for Augmented Reality and Virtual Reality

Robot-assisted surgery (RAS) systems represent a leading avenue for the integration of virtual reality (VR) and augmented reality (AR) technology in the operating room (OR). Live and virtual imaging featured on RAS user interfaces assist surgeon’s manipulation of robotic instruments and represent an open platform for the addition of VR and AR capabilities.


Two Potential Drug Pipeline "Disruptors" to Watch

Two Potential Drug Pipeline "Disruptors" to Watch

Kalorama's new report isolates potential drug pipeline "disruptors," new pharmaceuticals that could change future market leadership because of their effectiveness in a given disease area. In this article we look at two of them, a drug pipeline candidate in asthma and a drug pipeline candidate in lymphoma.

  • by Bruce Carlson
  • May 23 2017


SHERLOCK System Brings Potential for CRISPR Gene-Editing in Diagnostics

SHERLOCK System Brings Potential for CRISPR Gene-Editing in Diagnostics

CRISPR technology has already emerged as a revolutionary technology that is changing life science research and has the potential to dramatically change medicine. Now, CRISPR gene-editing in diagnostic testing is possible, with a new diagnostic platform called Specific High-Sensitivity Enzymatic Reporter UnLOCKing (SHERLOCK).